Shareholding disclosure
ADDEX THERAPEUTICS LTD
Declared position
52.18%
Threshold
Crossed downwards
Timeline
Published
05.12.2023
Transaction
27.11.2023
Voting rights breakdown
Voting rights acquired33.04%
Voting rights sold52.18%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TANBU000D2
Beneficial owner
ADDEX THERAPEUTICS LTD
Declared address
ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES
On November 27, 2023, the exercise price of 12'736'209 call options has been reduced from CHF 0.13 to CHF 0.043. Of these call options,12,527,235 have been exercised and 208,974 remain outstanding.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open